The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Heavy-ion tumor therapy: Physical and radiobiological benefits
Abstract
High-energy beams of charged nuclear particles (protons and heavier ions) offer significant advantages for the treatment of deep-seated local tumors in comparison to conventional megavolt photon therapy. Their physical depth-dose distribution in tissue is characterized by a small entrance dose and a distinct maximum (Bragg peak) near the end of range with a sharp fall-off at the distal edge. Taking full advantage of the well-defined range and the small lateral beam spread, modern scanning beam systems allow delivery of the dose with millimeter precision. In addition, projectiles heavier than protons such as carbon ions exhibit an enhanced biological effectiveness in the Bragg peak region caused by the dense ionization of individual particle tracks resulting in reduced cellular repair. This makes them particularly attractive for the treatment of radio-resistant tumors localized near organs at risk. While tumor therapy with protons is a well-established treatment modality with more than 60 000 patients treated worldwide, the application of heavy ions is so far restricted to a few facilities only. Nevertheless, results of clinical phase I-II trials provide evidence that carbon-ion radiotherapy might be beneficial in several tumor entities. This article reviews the progress in heavy-ion therapy, including physical and technical developments, radiobiological studies and models, as well as radiooncological studies. As a result of the promising clinical results obtained with carbon-ion beams in the past ten years at the Heavy Ion Medical Accelerator facility (Japan) and in a pilot project at GSI Darmstadt (Germany), the plans for new clinical centers for heavy-ion or combined proton and heavy-ion therapy have recently received a substantial boost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SRIM – The stopping and range of ions in matter (2010)
Ziegler, J. F., Ziegler, M. D., & Biersack, J. P. (2010) · Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2010.02.091 · Cited by 11,412 · cited 1×
“Fano, 1963; Ahlen, 1980; Sigmund, 2004; Ziegler et al., 2008".”
Recommendations of the International Commission on Radiological Protection
(1961) · Postgraduate Medical Journal · doi:10.1136/pgmj.37.425.168-b · Cited by 5,862
Zur Theorie des Durchgangs schneller Korpuskularstrahlen durch Materie
Bethe, H. (1930) · Annalen der Physik · doi:10.1002/andp.19303970303 · Cited by 4,076 · cited 1×
“Bethe, 1930; Bloch, 1933a, 1933b", here given in the relativistic version described by Fano !”
BackgroundThe linear-quadratic formula and progress in fractionated radiotherapy
Fowler, J. F. (1989) · The British Journal of Radiology · doi:10.1259/0007-1285-62-740-679 · Cited by 2,252
Monoenergetic beams of relativistic electrons from intense laser–plasma interactions
Mangles, S. P. D., Murphy, C. D., Najmudin, Z., Thomas, A. G. R., Collier, J. L., Dangor, A. E., Divall, E. J., Foster, P. S., Gallacher, J. G., Hooker, C. J., et al. (2004) · Nature · doi:10.1038/nature02939 · Cited by 1,977
ACTION OF X-RAYS ON MAMMALIAN CELLS
Puck, T. T., & Marcus, P. I. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.5.653 · Cited by 1,696 · cited 1×
“Puck and Marcus, 1956", cell proliferation is analyzed about 1–2 weeks after irradiation and cells are counted as survivors, if they have formed a colony with more than 50 daughter cells.”
BackgroundRadiological Use of Fast Protons
Wilson, R. R. (1946) · Radiology · doi:10.1148/47.5.487 · Cited by 1,403
Relative biological effectiveness (RBE) values for proton beam therapy
Paganetti, H., Niemierko, A., Ancukiewicz, M., Gerweck, L. E., Goitein, M., Loeffler, J. S., & Suit, H. D. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02754-2 · Cited by 1,364
Intensity-modulated radiation therapy, protons, and the risk of second cancers
Hall, E. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.027 · Cited by 1,110
The calibration of CT Hounsfield units for radiotherapy treatment planning
Schneider, U., Pedroni, E., & Lomax, A. (1996) · Physics in Medicine and Biology · doi:10.1088/0031-9155/41/1/009 · Cited by 1,093
Cited by
Ion acceleration by superintense laser-plasma interaction
Macchi, A., Borghesi, M., & Passoni, M. (2013) · Reviews of Modern Physics · doi:10.1103/revmodphys.85.751 · Cited by 1,460
Newhauser, W. D., & Zhang, R. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/8/r155 · Cited by 675
Physical basis of radiation protection in space travel
Durante, M., & Cucinotta, F. A. (2011) · Reviews of Modern Physics · doi:10.1103/revmodphys.83.1245 · Cited by 528
Charged particle therapy—optimization, challenges and future directions
Loeffler, J. S., & Durante, M. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.79 · Cited by 426
Assessing the risk of second malignancies after modern radiotherapy
Newhauser, W. D., & Durante, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3069 · Cited by 380
Elsässer, T., Weyrather, W. K., Friedrich, T., Durante, M., Iancu, G., Krämer, M., Kragl, G., Brons, S., Winter, M., Weber, K.-J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.014 · Cited by 351
Self-citationNuclear physics in particle therapy: a review
Durante, M., & Paganetti, H. (2016) · Reports on Progress in Physics · doi:10.1088/0034-4885/79/9/096702 · Cited by 345
Friedrich, T., Scholz, U., ElsaSser, T., Durante, M., & Scholz, M. (2013) · Journal of Radiation Research · doi:10.1093/jrr/rrs114 · Cited by 287
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Locy, H., de Mey, S., de Mey, W., De Ridder, M., Thielemans, K., & Maenhout, S. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02909 · Cited by 279
Tinganelli, W., & Durante, M. (2020) · Cancers · doi:10.3390/cancers12103022 · Cited by 267
Applied nuclear physics at the new high-energy particle accelerator facilities
Durante, M., Golubev, A., Park, W.-Y., & Trautmann, C. (2019) · Physics Reports · doi:10.1016/j.physrep.2019.01.004 · Cited by 72
Nuclear data for space radiation
Norbury, J. W., Miller, J., Adamczyk, A. M., Heilbronn, L. H., Townsend, L. W., Blattnig, S. R., Norman, R. B., Guetersloh, S. B., & Zeitlin, C. J. (2012) · Radiation Measurements · doi:10.1016/j.radmeas.2012.03.004 · Cited by 42
Metadata
- Authors
- Schardt, D., Elsässer, T., & Schulz-Ertner, D.
- Venue
- Reviews of Modern Physics
- Publisher
- American Physical Society (APS)
- Published
- 2010-02-19
- Volume
- 82
- Issue
- 1
- Pages
- 383-425
- ISSN
- 0034-6861 (ISSN-L)
- 1539-0756
- OpenAlex
- W2017529805
- Cited by
- 778
- References
- 123
- FWCI
- 30.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.